Published in Arch Surg on January 01, 1998
Splenomegaly should not be considered a contraindication for laparoscopic splenectomy. Ann Surg (1998) 1.37
Laparoscopic splenectomy in the management of benign and malignant hematologic diseases. JSLS (2006) 1.13
Laparoscopic accessory splenectomy for recurrent idiopathic thrombocytopenic purpura. JSLS (2008) 0.91
Long-term outcome after laparoscopic splenectomy related to hematologic diagnosis. Surg Endosc (2004) 0.91
Computed tomography to detect accessory spleens before laparoscopic splenectomy: is it necessary? Surg Endosc (2010) 0.89
Inadequate detection of accessory spleens and splenosis with laparoscopic splenectomy: a shortcoming of the laparoscopic approach inhematological diseases. Surg Endosc (1999) 0.89
Technical standardization of laparoscopic splenectomy: experience with 105 cases. Surg Endosc (2002) 0.87
Laparoscopic accessory splenectomy: the value of perioperative localization studies. Surg Endosc (2009) 0.87
Predictive factors for successful laparoscopic splenectomy in immune thrombocytopenic purpura: study of clinical and laboratory data. Surg Endosc (2006) 0.86
Postsplenectomy recurrence of idiopathic thrombocitopenic purpura: role of laparoscopic splenectomy in the treatment of accessory spleen. G Chir (2015) 0.82
Laparoscopic splenectomy in pediatric patients with hematologic diseases. JSLS (2000) 0.81
Evaluation of risk of splenosis during laparoscopic splenectomy in rat model. World J Surg (2001) 0.79
Contemporary pediatric splenectomy: continuing controversies. Pediatr Surg Int (2011) 0.76
Laparoscopic versus open splenectomy in children: a systematic review and meta-analysis. Pediatr Surg Int (2015) 0.76
Identification of accessory spleens during laparoscopic splenectomy is superior to preoperative computed tomography for detection of accessory spleens. JSLS (2013) 0.75
The author replies Surg Endosc (1999) 0.75
Use of a laparoscopic hand-assist device for accessory splenectomy. Surg Endosc (2004) 0.75
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology (2001) 6.88
Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (1999) 6.37
Randomised trial of endoscopic sphincterotomy with gallbladder left in situ versus open surgery for common bileduct calculi in high-risk patients. Lancet (1996) 3.81
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nat Genet (1998) 2.87
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. Science (1998) 2.84
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood (2001) 2.73
Complications of laparoscopic splenectomy. Arch Surg (2000) 2.71
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut (2009) 2.60
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther (2009) 2.54
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology (1995) 2.47
Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva. Am J Med Genet (2001) 2.24
Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma. J Clin Oncol (1994) 2.20
[Diagnosis of renal carcinoma in acquired cystic renal disease. Usefulness of echography in detection during subclinical phase]. Med Clin (Barc) (1991) 2.04
Clinical picture: amiodarone-induced thyroiditis. Lancet (2002) 2.03
Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology (1993) 1.97
Replicative adenoviruses for cancer therapy. Nat Biotechnol (2000) 1.89
CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet (2002) 1.86
Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol (1998) 1.81
Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med (1998) 1.79
Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1994) 1.71
Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood (1999) 1.66
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol (2002) 1.61
[Pseudoachalasia: a diagnosis to consider in the assessment of dysphagia]. Gastroenterol Hepatol (2000) 1.60
Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med (1992) 1.60
How, when, and why bile duct injury occurs. A comparison between open and laparoscopic cholecystectomy. Surg Endosc (1998) 1.57
Localization of an autosomal dominant retinitis pigmentosa gene to chromosome 7q. Nat Genet (1993) 1.55
Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest (2000) 1.51
Low section of the rectum during laparoscopic total mesorectal excision using the Contour device. Technical report. Surg Endosc (2006) 1.48
Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients. Br J Haematol (1996) 1.44
SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol (2007) 1.44
Cancer dissemination during laparoscopic surgery: tubes, gas, and cells. World J Surg (1998) 1.42
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology (1992) 1.42
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia (2012) 1.41
[Imaging diagnosis of hepatocellular carcinoma. Addendum to hepatocellular carcinoma: diagnosis, staging and treatment strategies]. Radiologia (2011) 1.39
[International diffusion of clinical trials carried out in Spain. An analysis based on their publication in scientific journals]. Med Clin (Barc) (1994) 1.39
[An analysis of Spanish biomedical journals by the impact factor]. Med Clin (Barc) (1992) 1.39
Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: a report of 12 patients from a single institution. Ann Oncol (1998) 1.37
Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. J Nucl Med (1988) 1.37
Splenomegaly should not be considered a contraindication for laparoscopic splenectomy. Ann Surg (1998) 1.37
Laparoscopic splenectomy: an evolving technique. A comparison between anterior and lateral approaches. Surg Endosc (1996) 1.36
Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J (1996) 1.36
PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res (1994) 1.34
Mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa: high prevalence and phenotypic variation. J Med Genet (2003) 1.31
Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance. Diabetologia (2003) 1.30
Correction of diabetic alterations by glucokinase. Proc Natl Acad Sci U S A (1996) 1.30
Genetic heterogeneity of Usher syndrome: analysis of 151 families with Usher type I. Am J Hum Genet (2000) 1.29
Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.29
Structure and expression of three genes encoding ACC oxidase homologs from melon (Cucumis melo L.). Mol Gen Genet (1996) 1.28
Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II. J Med Genet (2006) 1.27
Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice. Diabetologia (2008) 1.25
Central nervous system involvement in mantle cell lymphoma. Ann Oncol (2007) 1.22
NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors. Carcinogenesis (2000) 1.21
Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis (2000) 1.21
Identification of novel RP2 mutations in a subset of X-linked retinitis pigmentosa families and prediction of new domains. Hum Mutat (2001) 1.19
The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol (2006) 1.18
Prenatal diagnosis of skeletal dysplasia due to FGFR3 gene mutations: a 9-year experience : prenatal diagnosis in FGFR3 gene. J Assist Reprod Genet (2009) 1.17
A new locus for autosomal recessive retinitis pigmentosa (RP19) maps to 1p13-1p21. Genomics (1997) 1.16
Cloning of a gene involved in rRNA precursor processing and 23S rRNA cleavage in Rhodobacter capsulatus. J Bacteriol (1994) 1.16
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood (1996) 1.16
Epidermal growth factor mimics insulin effects in rat hepatocytes. Biochem J (1986) 1.14
Novel mutations in the TULP1 gene causing autosomal recessive retinitis pigmentosa. Invest Ophthalmol Vis Sci (2000) 1.12
Hand-assisted laparoscopic splenectomy (HALS) in cases of splenomegaly: a comparison analysis with conventional laparoscopic splenectomy. Surg Endosc (2001) 1.12
Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer (2000) 1.12
Chronic lymphocytic leukemia: a changing natural history? Leukemia (1997) 1.10
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology (2000) 1.10
Clinical and genetic studies in Spanish patients with Usher syndrome type II: description of new mutations and evidence for a lack of genotype--phenotype correlation. Clin Genet (2005) 1.09
Evidence from transgenic mice that myc regulates hepatic glycolysis. FASEB J (1995) 1.08
Effect of spleen size on splenectomy outcome. A comparison of open and laparoscopic surgery. Surg Endosc (1999) 1.08
An epidemiological comparison of pain complaints in the general population of Catalonia (Spain). Pain (1999) 1.08
The epileptogenic effect of tranexamic acid. J Neurol (1999) 1.07
Mutation profile of the MYO7A gene in Spanish patients with Usher syndrome type I. Hum Mutat (2006) 1.07
Could age be an indication for laparoscopic colectomy in colorectal cancer? Surg Endosc (2000) 1.07
The spilled stone. A potential danger after laparoscopic cholecystectomy. Surg Endosc (1995) 1.06
Laparoscopic surgery and surgical infection. Br J Surg (2000) 1.05
Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever. J Hepatol (1995) 1.05
CNS involvement in mantle-cell lymphoma. J Clin Oncol (1996) 1.05
Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes. J Biol Chem (1986) 1.05
Homozygous tandem duplication within the gene encoding the beta-subunit of rod phosphodiesterase as a cause for autosomal recessive retinitis pigmentosa. Hum Mutat (1995) 1.05
MYO7A mutation screening in Usher syndrome type I patients from diverse origins. J Med Genet (2007) 1.05
Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum Gene Ther (1994) 1.04
Study of the involvement of the RGR, CRPB1, and CRB1 genes in the pathogenesis of autosomal recessive retinitis pigmentosa. J Med Genet (2003) 1.04
Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families. Hum Genet (1995) 1.02
Pyoderma gangrenosum triggered by alpha2b-interferon in a patient with chronic granulocytic leukemia. Leuk Lymphoma (1998) 1.02
Mucosal mantle cell (centrocytic) lymphomas. Histopathology (1995) 1.00
In vivo genetic engineering of murine pancreatic beta cells mediated by single-stranded adeno-associated viral vectors of serotypes 6, 8 and 9. Diabetologia (2011) 1.00
[The Pro347Leu mutation of the rhodopsin gene in a Spanish family with autosomal dominant pigmentary retinosis]. Med Clin (Barc) (1998) 0.99
Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia (2008) 0.99